-
-
-
-
-
-
-
Raymond James Downgrades DaVita (DVA) to Market Perform
-
-
-
-
-
-
-
DaVita (DVA) to Acquire Renal Ventures in $415M Deal
-
-
-
-
-
-
-
Raymond James Reiterates an 'Outperform' on Amgen (AMGN); DaVita Contract Revelation Indicates Near-Term Upside on EPO Pricing
-
-
-
33,769 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

